R. Vlădăreanu *, Ana Maria Vlădăreanu **, Irina Pacu ***
* Dr. Radu Vlădăreanu, medic primar obstetrică ginecologie, şef de lucrări UMF Carol Davila, doctor în ştiinţe medicale, Clinica de obstetrică ginocologie Spitalul Sf. Pantelimon
** Dr. Ana Maria Vlădăreanu, medic primar hematologie, asistent universitar UMF Carol Davila, doctor în ştiinţe medicale, Clinica de Hematologie Colţea
*** Dr. Irina Pacu, medic rezident obstetrică ginecologie, preparator UMF “Carol Davila”
Abstract
Menorrhagia – menstrual periods lasting longer than 7 days and totaling blood losses greater than 80 ml – affects 9% – 14% of otherwise healthy women, and it can signal cancer. and endocrinologic disorder, or gynecologic disease. Treatment can be medical or surgical. Medical treatment includes prostaglandin inhibitors, specifically nonsteroidal antiinflammatory drugs (NSAIDs), and hormonal therapy with estrogen, progesterone, gonadotropin-releasing hormone agonists, or oral contraceptives such as medroxyprogesterone (Depo- Provera). Surgical treatment includes hysteroscopic endometrial ablation by physical agents. laser electrodiathermy, and “roller ball”, or surgical, resection. Hysterectomy is the treatment of last resort.